» Articles » PMID: 35260560

Targeting Ferroptosis Suppresses Osteocyte Glucolipotoxicity and Alleviates Diabetic Osteoporosis

Overview
Journal Bone Res
Date 2022 Mar 9
PMID 35260560
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic osteoporosis (DOP) is the leading complication continuously threatening the bone health of patients with diabetes. A key pathogenic factor in DOP is loss of osteocyte viability. However, the mechanism of osteocyte death remains unclear. Here, we identified ferroptosis, which is iron-dependent programmed cell death, as a critical mechanism of osteocyte death in murine models of DOP. The diabetic microenvironment significantly enhanced osteocyte ferroptosis in vitro, as shown by the substantial lipid peroxidation, iron overload, and aberrant activation of the ferroptosis pathway. RNA sequencing showed that heme oxygenase-1 (HO-1) expression was notably upregulated in ferroptotic osteocytes. Further findings revealed that HO-1 was essential for osteocyte ferroptosis in DOP and that its promoter activity was controlled by the interaction between the upstream NRF2 and c-JUN transcription factors. Targeting ferroptosis or HO-1 efficiently rescued osteocyte death in DOP by disrupting the vicious cycle between lipid peroxidation and HO-1 activation, eventually ameliorating trabecular deterioration. Our study provides insight into DOP pathogenesis, and our results provide a mechanism-based strategy for clinical DOP treatment.

Citing Articles

Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway.

Lei S, Wang Y, Huang X, Wang X, Gao M, Li B Mol Med. 2025; 31(1):101.

PMID: 40089686 DOI: 10.1186/s10020-025-01152-2.


Transcriptomic analysis revealed ferroptosis in ducklings with splenic necrosis induced by NDRV infection.

Wang H, Jiang C, Xu B, Lei D, Fang R, Tang Y Vet Res. 2025; 56(1):54.

PMID: 40059215 PMC: 11892222. DOI: 10.1186/s13567-025-01479-y.


The role of programmed cell death in diabetes mellitus-induced erectile dysfunction: from mechanisms to targeted therapy.

Zhang J, Xin S, Mao J, Liu X, Wang T, Liu J Reprod Biol Endocrinol. 2025; 23(1):32.

PMID: 40033391 PMC: 11874627. DOI: 10.1186/s12958-025-01368-1.


Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus.

Xian Y, Liu B, Shen T, Yang L, Peng R, Shen H Bone Res. 2025; 13(1):30.

PMID: 40025004 PMC: 11873136. DOI: 10.1038/s41413-024-00399-5.


The Gut Microbiota Metabolite Butyrate Modulates Acute Stress-Induced Ferroptosis in the Prefrontal Cortex via the Gut-Brain Axis.

Wang Z, Ma X, Shi W, Zhu W, Feng X, Xin H Int J Mol Sci. 2025; 26(4).

PMID: 40004161 PMC: 11855447. DOI: 10.3390/ijms26041698.


References
1.
Napoli N, Chandran M, Pierroz D, Abrahamsen B, Schwartz A, Ferrari S . Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2016; 13(4):208-219. DOI: 10.1038/nrendo.2016.153. View

2.
Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

3.
Shanbhogue V, Hansen S, Frost M, Brixen K, Hermann A . Bone disease in diabetes: another manifestation of microvascular disease?. Lancet Diabetes Endocrinol. 2017; 5(10):827-838. DOI: 10.1016/S2213-8587(17)30134-1. View

4.
Kim J, Kim A, Choi Y, Jang S, Woo G, Cha J . Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis. PLoS One. 2017; 12(12):e0189702. PMC: 5730195. DOI: 10.1371/journal.pone.0189702. View

5.
Lai X, Price C, Modla S, Thompson W, Caplan J, Kirn-Safran C . The dependences of osteocyte network on bone compartment, age, and disease. Bone Res. 2015; 3. PMC: 4511381. DOI: 10.1038/boneres.2015.9. View